newsfilter
← Latest News
PR Newswire·

Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of Directors

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced the appointment of biotechnology...